105 research outputs found
LASER AND MULTI-IMAGE REVERSE ENGINEERING SYSTEMS FOR ACCURATE 3D MODELLING OF COMPLEX CULTURAL ARTEFACTS
The recent scientific and technical developments of reverse engineering methods and tools have broadened the possibilities of applications in the field of cultural heritage conservation. In this paper, two different non-contact reverse engineering systems were utilized for 3D data acquisition of a cultural heritage artefact. The object of interest is a 17th century wooden engraved ecclesiastical sanctuary ciborium. The requirement of the 3D model is to aid the art conservators for the preservation of the wooden material and the restoration of small damages and cracks in the engraved parts, thus requiring accuracy of the model in the order of sub-millimetre. In this work, a Faro Vantage laser tracker was employed along with the FARO Edge Arm. In addition, image-based modelling was also implemented with a large number of overlapping images acquired with a Canon EOS 6D camera and processed using the well-known Structure from Motion (SfM) method with an auto-calibration procedure. The digital data acquisition and processing procedures of the scanned geometry are described and compared to evaluate the performance of both systems in terms of data acquisition time, processing time, reconstruction precision and final model quality. Whilst models produced with laser scanning and image-based techniques is not a novel approach, the combination of laser tracking and photogrammetric data still presents limited documentation in the field of cultural artefact documentation mainly due to the extremely high cost of the laser tracking systems
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci.
We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120 controls of European descent from five studies followed by a replication strategy, which included 8,382 cases and 48,275 controls from 16 studies. In a combined analysis, we identified three new regions associated with bladder cancer on chromosomes 22q13.1, 19q12 and 2q37.1: rs1014971, (P = 8 × 10⁻¹²) maps to a non-genic region of chromosome 22q13.1, rs8102137 (P = 2 × 10⁻¹¹) on 19q12 maps to CCNE1 and rs11892031 (P = 1 × 10⁻⁷) maps to the UGT1A cluster on 2q37.1. We confirmed four previously identified genome-wide associations on chromosomes 3q28, 4p16.3, 8q24.21 and 8q24.3, validated previous candidate associations for the GSTM1 deletion (P = 4 × 10⁻¹¹) and a tag SNP for NAT2 acetylation status (P = 4 × 10⁻¹¹), and found interactions with smoking in both regions. Our findings on common variants associated with bladder cancer risk should provide new insights into the mechanisms of carcinogenesis
A stakeholder co-design approach for developing a community pharmacy service to enhance screening and management of atrial fibrillation
The authors would like to thank all participants in this research for their
valuable input into the co-design process.Background: Community pharmacies provide a suitable setting to promote self-screening programs aimed at
enhancing the early detection of atrial fibrillation (AF). Developing and implementing novel community pharmacy
services (CPSs) is a complex and acknowledged challenge, which requires comprehensive planning and the
participation of relevant stakeholders. Co-design processes are participatory research approaches that can enhance
the development, evaluation and implementation of health services. The aim of this study was to co-design a
pharmacist-led CPS aimed at enhancing self-monitoring/screening of AF.
Methods: A 3-step co-design process was conducted using qualitative methods: (1) interviews and focus group
with potential service users (n = 8) to identify key needs and concerns; (2) focus group with a mixed group of
stakeholders (n = 8) to generate a preliminary model of the service; and (3) focus group with community pharmacy
owners and managers (n = 4) to explore the feasibility and appropriateness of the model. Data were analysed
qualitatively to identify themes and intersections between themes. The JeMa2 model to conceptualize pharmacybased
health programs was used to build a theoretical model of the service.
Results: Stakeholders delineated: a clear target population (i.e., individuals ≥65 years old, with hypertension, with or
without previous AF or stroke); the components of the service (i.e., patient education; self-monitoring at home;
results evaluation, referral and follow-up); and a set of circumstances that may influence the implementation of the
service (e.g., quality of the service, competency of the pharmacist, inter-professional relationships, etc.). A number of
strategies were recommended to enable implementation (e.g.,. endorsement by leading cardiovascular
organizations, appropriate communication methods and channels between the pharmacy and the general medical
practice settings, etc.).
Conclusion: A novel and preliminary model of a CPS aimed at enhancing the management of AF was generated
from this participatory process. This model can be used to inform decision making processes aimed at adopting
and piloting of the service. It is expected the co-designed service has been adapted to suit existing needs of
patients and current care practices, which, in turn, may increase the feasibility and acceptance of the service when
it is implemented into a real setting.This work was funded by Covidien Pty Ltd. (Medtronic Australasia Pty Ltd)
[UTS Project code: PRO16–0688], which is the company that has the rights to distribute the device Microlife BP A200 AFIB in Australia. Also, funding for
this research has been provided by a UTS Chancellor’s postdoctoral
fellowship awarded to the first author of this article (ID number:
2013001605)
Lung transplantation for pulmonary fibrosis in dyskeratosis congenita: Case Report and systematic literature review
<p>Abstract</p> <p>Background</p> <p>Dyskeratosis congenita (DC) is a progressive, multi-system, inherited disorder of telomere biology with high risks of morbidity and mortality from bone marrow failure, hematologic malignancy, solid tumors and pulmonary fibrosis. Hematopoietic stem cell transplantation (HSCT) can cure the bone marrow failure, but it does not eliminate the risks of other complications, for which life-long surveillance is required. Pulmonary fibrosis is a progressive and lethal complication of DC.</p> <p>Case presentation</p> <p>In this report, we describe a patient with DC who developed pulmonary fibrosis seven years after HSCT for severe aplastic anemia, and was successfully treated with bilateral lung transplantation. We also performed a systematic literature review to understand the burden of pulmonary disease in patients with DC who did or did not receive an HSCT. Including our patient, we identified 49 DC patients with pulmonary disease (12 after HSCT and 37 without HSCT), and 509 with no reported pulmonary complications.</p> <p>Conclusion</p> <p>Our current case and literature review indicate that pulmonary morbidity is one of the major contributors to poor quality of life and reduced long-term survival in DC. We suggest that lung transplantation be considered for patients with DC who develop pulmonary fibrosis with no concurrent evidence of multi-organ failure.</p
Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway
Ancestral Mutation in Telomerase Causes Defects in Repeat Addition Processivity and Manifests As Familial Pulmonary Fibrosis
The telomerase reverse transcriptase synthesizes new telomeres onto chromosome ends by copying from a short template within its integral RNA component. During telomere synthesis, telomerase adds multiple short DNA repeats successively, a property known as repeat addition processivity. However, the consequences of defects in processivity on telomere length maintenance are not fully known. Germline mutations in telomerase cause haploinsufficiency in syndromes of telomere shortening, which most commonly manifest in the age-related disease idiopathic pulmonary fibrosis. We identified two pulmonary fibrosis families that share two non-synonymous substitutions in the catalytic domain of the telomerase reverse transcriptase gene hTERT: V791I and V867M. The two variants fell on the same hTERT allele and were associated with telomere shortening. Genealogy suggested that the pedigrees shared a single ancestor from the nineteenth century, and genetic studies confirmed the two families had a common founder. Functional studies indicated that, although the double mutant did not dramatically affect first repeat addition, hTERT V791I-V867M showed severe defects in telomere repeat addition processivity in vitro. Our data identify an ancestral mutation in telomerase with a novel loss-of-function mechanism. They indicate that telomere repeat addition processivity is a critical determinant of telomere length and telomere-mediated disease
Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer
The effect of blocking VEGF activity in solid tumors extends beyond inhibition of angiogenesis. However, no studies have compared the effectiveness of mechanistically different anti-VEGF inhibitors with respect to changes in tumor growth and alterations in the tumor microenvironment. In this study we use three distinct breast cancer models, a MDA-MB-231 xenograft model, a 4T1 syngenic model, and a transgenic model using MMTV-PyMT mice, to explore the effects of various anti-VEGF therapies on tumor vasculature, immune cell infiltration, and cytokine levels. Tumor vasculature and immune cell infiltration were evaluated using immunohistochemistry. Cytokine levels were evaluated using ELISA and electrochemiluminescence. We found that blocking the activation of VEGF receptor resulted in changes in intra-tumoral cytokine levels, specifically IL-1β, IL-6 and CXCL1. Modulation of the level these cytokines is important for controlling immune cell infiltration and ultimately tumor growth. Furthermore, we demonstrate that selective inhibition of VEGF binding to VEGFR2 with r84 is more effective at controlling tumor growth and inhibiting the infiltration of suppressive immune cells (MDSC, Treg, macrophages) while increasing the mature dendritic cell fraction than other anti-VEGF strategies. In addition, we found that changes in serum IL-1β and IL-6 levels correlated with response to therapy, identifying two possible biomarkers for assessing the effectiveness of anti-VEGF therapy in breast cancer patients
Development and field testing of a multi-antenna GPS system for deformation monitoring
Lung epithelial stem cells and their niches : Fgf10 takes center stage
Throughout life adult animals crucially depend on stem cell populations to maintain and repair their tissues to ensure life-long organ function. Stem cells are characterized by their capacity to extensively self-renew and give rise to one or more differentiated cell types. These powerful stem cell properties are key to meet the changing demand for tissue replacement during normal lung homeostasis and regeneration after lung injury. Great strides have been made over the last few years to identify and characterize lung epithelial stem cells as well as their lineage relationships. Unfortunately, knowledge on what regulates the behavior and fate specification of lung epithelial stem cells is still limited, but involves communication with their microenvironment or niche, a local tissue environment that hosts and influences the behaviors or characteristics of stem cells and that comprises other cell types and extracellular matrix. As such, an intimate and dynamic epithelial-mesenchymal cross-talk, which is also essential during lung development, is required for normal homeostasis and to mount an appropriate regenerative response after lung injury. Fibroblast growth factor 10 (Fgf10) signaling in particular seems to be a well-conserved signaling pathway governing epithelial-mesenchymal interactions during lung development as well as between different adult lung epithelial stem cells and their niches. On the other hand, disruption of these reciprocal interactions leads to a dysfunctional epithelial stem cell-niche unit, which may culminate in chronic lung diseases such as chronic obstructive pulmonary disease (COPD), chronic asthma and idiopathic pulmonary fibrosis (IPF)
The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia
Genome-wide association studies of lung cancer reported in populations of European background have identified three regions on chromosomes 5p15.33, 6p21.33, and 15q25 that have achieved genome-wide significance with p-values of 10−7 or lower. These studies have been performed primarily in cigarette smokers, raising the possibility that the observed associations could be related to tobacco use, lung carcinogenesis, or both. Since most women in Asia do not smoke, we conducted a genome-wide association study of lung adenocarcinoma in never-smoking females (584 cases, 585 controls) among Han Chinese in Taiwan and found that the most significant association was for rs2736100 on chromosome 5p15.33 (p = 1.30×10−11). This finding was independently replicated in seven studies from East Asia totaling 1,164 lung adenocarcinomas and 1,736 controls (p = 5.38×10−11). A pooled analysis achieved genome-wide significance for rs2736100. This SNP marker localizes to the CLPTM1L-TERT locus on chromosome 5p15.33 (p = 2.60×10−20, allelic risk = 1.54, 95% Confidence Interval (CI) 1.41–1.68). Risks for heterozygote and homozygote carriers of the minor allele were 1.62 (95% CI; 1.40–1.87), and 2.35 (95% CI: 1.95–2.83), respectively. In summary, our results show that genetic variation in the CLPTM1L-TERT locus of chromosome 5p15.33 is directly associated with the risk of lung cancer, most notably adenocarcinoma
- …